Johnson & Johnson

Trump to sign order to cut some U.S. drug prices to match lower ones abroad
President Donald Trump on Monday will revive a controversial policy that aims to slash drug costs by tying the amount the government pays for some medicines to lower prices abroad, White House officials said. Trump will sign an executive order including several different actions to renew that effort, known as the “most favored nation” policy. […]
Read More
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
US President Donald Trump speaks during a cabinet meeting in the Cabinet Room of the White House in Washington, DC, on April 30, 2025. Jim Watson | Afp | Getty Images President Donald Trump on Monday signed an executive order to incentivize drug manufacturing in the U.S., streamlining the path for pharmaceutical companies to build […]
Read More
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Jgi/jamie Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Tariff threats — and efforts to get into President Donald Trump’s good graces — are fueling a new wave […]
Read More
GE HealthCare beats on earnings, slashes full year outlook due to tariffs
GE HealthCare reported better-than-expected first-quarter results on Wednesday, but the company slashed its annual forecast to account for the impact of President Donald Trump’s far-reaching “reciprocal” tariff policy. Shares of GE HealthCare were up 3% on Wednesday. Here’s how the company did: Earnings per share: $1.01 adjusted vs. 91 cents expected by LSEG. Revenue: $4.78 […]
Read More
Why we’re lowering our Bristol Myers price target despite an earnings beat, guidance raise
Bristol Myers Squibb ‘s earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock. But it was enough, for now. Revenue in the first quarter, which ended March 31, dipped 6% to $11.2 billion but topped estimates of $10.7 billion, according to LSEG. Adjusted earnings per share of $1.80 beat expectations […]
Read More
Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs
A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024. Nurphoto | Nurphoto | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to […]
Read More
Medical product manufacturers are divided over Trump’s tariffs
President Donald Trump’s tariffs are creating a divide in the medical community. Medical devices and protective gear made in China, Mexico and Canada were exempt from duties during the first Trump administration, but so far have not gotten a reprieve from his newest round of levies. While device makers who would take a big hit […]
Read More
Stocks making the biggest moves premarket: Bank of America, Boeing, Johnson & Johnson and more
Check out the companies making headlines before the bell. Bank of America — Shares rose about 2% after Bank of America reported first-quarter results that exceeded analysts’ expectations , due to stronger-than-expected net interest income and trading revenue. The bank’s quarterly earnings rose 11% to $7.4 billion, or 90 cents a share, while its revenue increased 5.9% […]
Read More